DiMarchi, who was a vice president at Eli Lilly and involved in GLP-1 research there, until he left the company in 2003, is that many diseases may share the same root causes, even though we label them and treat them as distinct: This is an endocrine disease, this is a cardiovascular disease, this is a brain disease. This root-cause theory suggests that a wide range of conditions can be treatable with one drug class, sometimes through pathways in the brain and the immune system
Yu, M., Jin, X., Liang, C., Bu, F., Pan, D., He, Q., Ming, Y., Little, P., Du, H., Liang, S., Hu, R., Li, C., Hu, Y
Here's what real-world results look like: Measurable Improvements Sleep specialists measure sleep apnea severity using the Apnea-Hypopnea Index (AHI), which counts how many breathing pauses you experience per hour: Mild sleep apnea : 5-15 events per hour Moderate sleep apnea : 15-30 events per hour Severe sleep apnea : More than 30 events per hour With GLP-1 medications, many patients see their AHI numbers drop significantlysometimes by more than 50%
Improves skin elasticity and firmness
This protein binds to vitamin B12, which allows your body to absorb it into the blood